Neuronetics, Inc. (NASDAQ:STIM) has seen 670,435 shares traded in the last trading session. The company, currently valued at $39.33 Million, closed the last trade at $2.1 per share which meant it lost $0 on the day or 0% during that session. The STIM stock price is -533.81% off its 52-week high price of $13.31 and 40.48% above the 52-week low of $1.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.83 Million shares traded. The 3-month trading volume is 555.93 Million shares.
The consensus among analysts is that Neuronetics, Inc. (STIM) is an Overweight stock at the moment, with a recommendation rating of 1.8. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 4 have rated it as a Hold, with 3 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.51.
Neuronetics, Inc. (NASDAQ:STIM) trade information
Despite being 0% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jun 23 when the STIM stock price touched $3.06-3 or saw a rise of 31.37%. Year-to-date, Neuronetics, Inc. shares have moved -53.23%, while the 5-day performance has seen it change 15.38%. Over the past 30 days, the shares of Neuronetics, Inc. (NASDAQ:STIM) have changed 4.48%. Short interest in the company has seen 825.14 Million shares shorted with days to cover at 1.48.
Wall Street analysts have a consensus price target for the stock at $5.33, which means that the shares’ value could jump 153.81% from current levels. The projected low price target is $4 while the price target rests at a high of $6. In that case, then, we find that the current price level is +185.71% off the targeted high while a plunge would see the stock lose 90.48% from current levels.
Neuronetics, Inc. (STIM) estimates and forecasts
Figures show that Neuronetics, Inc. shares have outperformed across the wider relevant industry. The company’s shares have lost -52.7% over the past 6 months, with this year growth rate of 9.49%, compared to 2.9% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -30.8% and 2.7% for the next quarter. Revenue growth from the last financial year stood is estimated to be -27.7%.
4 analysts offering their estimates for the company have set an average revenue estimate of $8.38 Million for the current quarter. 4 have an estimated revenue figure of $11.08 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $16.57 Million and $16.19 Million respectively for this quarter and the next, and analysts expect sales will grow by -49.4% for the current quarter and -31.6% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest +41.3% while over the next 5 years, the company’s earnings are expected to increase by 0%.
Neuronetics, Inc. (NASDAQ:STIM)’s Major holders
Insiders own 5.4% of the company shares, while shares held by institutions stand at 76.08% with a share float percentage of 80.42%. Investors are also buoyed by the number of investors in a company, with Neuronetics, Inc. having a total of 100 institutions that hold shares in the company. The top two institutional holders are Investor AB with over 1.79 Million shares worth more than $3.39 Million. As of March 30, 2020, Investor AB held 9.58% of shares outstanding.
The other major institutional holder is Deerfield Management Company, L.P. (Series C), with the holding of over 1.58 Million shares as of March 30, 2020. The firm’s total holdings are worth over $2.98 Million and represent 8.41% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Smallcap World Fund and iShares Russell 2000 ETF. As of December 30, 2019, the former fund manager holds about 3.94% shares in the company for having 737602 shares of worth $3.31 Million while later fund manager owns 316.36 Thousand shares of worth $597.91 Thousand as of March 30, 2020, which makes it owner of about 1.69% of company’s outstanding stock.